Emboline, Inc. secures $20 million in growth capital from Trinity Capital Inc. to advance their interventional heart procedure technology and prepare for the commercial launch of the Emboliner system.
Trinity Capital Inc. has announced a commitment of $20 million in growth capital to Emboline, Inc., a MedTech company focused on interventional heart procedures. This funding will support Emboline's efforts to commercialize their Emboliner system, enhancing patient safety. The company is advancing through clinical trials and regulatory approvals for their innovative technology
Who to call at Emboline Inc, and when
A new round usually means Emboline Inc is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Emboline Inc raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Emboline Inc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Emboline Inc. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Emboline Inc
Location
849C ALMAR AVE., #278
California, United States
About
Emboline, Inc. is a privately held medical technology company that has developed the Emboliner® Embolic Protection Catheter, the first embolic protection device to provide full brain and body embolic protection by capturing and removing all debris from transcatheter. Emboline has the earliest, broadest, and deepest intellectual property portfolio in the field of aortic embolic protection, with the strategic acquisition further strengthening and extending that portfolio.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Emboline Inc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.